Deal Dispatch: Sage And Silvus Are Up For Sale, MrBeast Secures $20B For TikTok

BenzingaJan 31 14:20 ET

Allakos Faces Strategic Uncertainty Following AK006 Phase 1 Trial Failure and Workforce Reduction

TipRanksJan 29 01:15 ET

Allakos Cuts 75% of Workforce After Chronic Hives Trial Failure

Yahoo FinanceJan 28 13:37 ET

Institutional Owners May Consider Drastic Measures as Allakos Inc.'s (NASDAQ:ALLK) Recent US$55m Drop Adds to Long-term Losses

Simply Wall StJan 28 09:32 ET

Hold Rating on Allakos Amid Clinical and Financial Setbacks With AK006

TipRanksJan 28 07:35 ET · Ratings

12 Health Care Stocks Moving In Monday's Pre-Market Session

BenzingaJan 27 16:05 ET

Akero AKRO Phase 2b Success; Allakos ALLK Strategic Alternatives

BioPharmCatalystJan 27 15:50 ET

Why Is Allakos Stock Plunging On Monday?

BenzingaJan 27 14:05 ET

Top Midday Decliners

MT NewswiresJan 27 13:52 ET

Analysts Offer Insights on Healthcare Companies: Lexicon Pharmaceuticals (LXRX) and Allakos (ALLK)

TipRanksJan 27 12:30 ET · Ratings

Dow Edges Higher; AT&T Posts Upbeat Earnings

BenzingaJan 27 12:05 ET

TD Cowen Maintains Allakos(ALLK.US) With Hold Rating

Moomoo NewsJan 27 10:31 ET · Ratings

Allakos Shares Plummet to All-Time Low After Lead Candidate Failure

WSJJan 27 10:23 ET

Allakos Downgraded to Neutral From Overweight at Piper Sandler

TipRanksJan 27 10:00 ET · Ratings

Hold Rating Maintained for Allakos Amid AK006 Program Discontinuation and Strategic Uncertainty

TipRanksJan 27 09:45 ET

Nasdaq Dips 3%; Chicago Fed National Activity Index Rises In December

BenzingaJan 27 09:43 ET

JMP Securities Downgrades Allakos(ALLK.US) to Hold Rating

Moomoo NewsJan 27 09:33 ET · Ratings

Sector Update: Health Care Stocks Mixed Premarket Monday

MT NewswiresJan 27 09:11 ET

Allakos ALLK Phase 1 Discontinuation; Akero AKRO Phase 2b Data

BioPharmCatalystJan 27 09:11 ET

Allakos Plunges 75% on Phase 1 Data for Urticaria Asset

Seeking AlphaJan 27 08:54 ET